Financial Advisor. Except as disclosed in Part 2.23 of the Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of any of the Acquired Companies.
Appears in 2 contracts
Samples: Merger Agreement (Conexant Systems Inc), Merger Agreement (Acquicor Technology Inc)
Financial Advisor. Except as disclosed in set forth on Part 2.23 3.14 of the Parent Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of any of the Acquired CompaniesParent.
Appears in 2 contracts
Samples: Merger Agreement (Acelrx Pharmaceuticals Inc), Merger Agreement (Tetraphase Pharmaceuticals Inc)
Financial Advisor. Except as disclosed in Part 2.23 of the Disclosure Scheduleset forth on Schedule 4.13, no broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission in connection with the Merger Transaction or any of the other Contemplated Transactions based upon arrangements made by or on behalf of any of the Acquired CompaniesParent.
Appears in 2 contracts
Samples: Acquisition Agreement, Acquisition Agreement (Marika Inc.)
Financial Advisor. Except as disclosed in set forth on Part 2.23 4.6 of the Parent Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission in connection with the Offer, the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of any of the Acquired Companieseither Parent or Merger Sub.
Appears in 2 contracts
Samples: Agreement and Plan of Merger (Allos Therapeutics Inc), Merger Agreement (Spectrum Pharmaceuticals Inc)
Financial Advisor. Except as disclosed set forth in Part 2.23 Section 4.13 of the Parent Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of Parent or Transitory Subsidiary respect of any of the Acquired Companiestransactions contemplated hereby.
Appears in 1 contract
Financial Advisor. Except as disclosed in set forth on Part 2.23 3.15 of the Parent Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of any of the Acquired Companies.Parent. 3.16
Appears in 1 contract
Financial Advisor. Except as disclosed set forth in Part 2.23 3.16 of the Parent Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage, finder’s 's or other fee or commission in connection with the Merger or any of the other Contemplated Transactions transactions contemplated by this Agreement based upon arrangements made by or on behalf of any of the Acquired CompaniesParent or Merger Sub.
Appears in 1 contract
Samples: Merger Agreement (Pharmacopeia Inc)
Financial Advisor. Except as disclosed set forth in Part 2.23 Section 4.10 of the Parent Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission in connection with the Merger or any of the other Contemplated Transactions based upon arrangements made by or on behalf of Parent or Transitory Subsidiary in respect of any of the Acquired Companiestransactions contemplated hereby.
Appears in 1 contract
Samples: Agreement and Plan of Merger and Reorganization (Eliem Therapeutics, Inc.)
